Notes: October 17, 2022 -- 9 Meters Biopharma, Inc. (the “Company”) filed a Certificate of Amendment to its Amended and Restated Certificate of Incorporation, as amended (the “Certificate of Amendment”) with the Secretary of State of Delaware for the purpose of effecting a reverse stock split (the “Reverse Stock Split”) of the outstanding shares of the Company’s common stock at a ratio of one (1) share for every twenty (20) shares outstanding, so that every twenty (20) outstanding shares of common stock before the Reverse Stock Split represents one (1) share of common stock after the Reverse Stock Split. The Reverse Stock Split, which was approved by our stockholders at the annual meeting of stockholders held on June 22, 2022, was effective at 5:00 p.m. on October 17, 2022. The new CUSIP number following the reverse stock split will be 654405208 <p> April 30, 2020 -- Innovate Biopharmaceuticals, Inc. (Nasdaq:INNT), today announced the completion of its previously announced merger with privately-held RDD Pharma, Ltd. Following the completion of the merger with RDD Pharma, Innovate is changing its name to 9 Meters Biopharma, Inc. ("9 Meters" or the "Company") and will continue trading on NASDAQ with the ticker symbol NMTR, effective May 4, 2020. _______________ January 29, 2018 -- Monster Digital, Inc. effected a reverse merger with Innovate Biopharmaceuticals, Inc. and changed its name to Innovate Biopharmaceuticals, Inc. In connection with the merger, All operations were transferred to a new entity and are now conducted under SDJ Technologies, Inc.